Sol-Gel Technologies Ltd. (SLGL)
81.72
+4.33
(+5.60%)
USD |
NASDAQ |
Aug 25, 16:00
Sol-Gel Technologies EPS Diluted (Quarterly) : -1.126 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.126 |
| March 31, 2026 | -1.314 |
| December 31, 2025 | -1.072 |
| September 30, 2025 | -2.133 |
| June 30, 2025 | 4.168 |
| March 31, 2025 | -3.162 |
| December 31, 2024 | -2.098 |
| September 30, 2024 | -0.0131 |
| June 30, 2024 | 0.0709 |
| March 31, 2024 | -0.2277 |
| December 31, 2023 | -0.1736 |
| September 30, 2023 | -0.2051 |
| June 30, 2023 | -0.2158 |
| March 31, 2023 | -4.298 |
| December 31, 2022 | -0.2501 |
| September 30, 2022 | -0.1473 |
| June 30, 2022 | -0.0058 |
| March 31, 2022 | -0.242 |
| December 31, 2021 | 0.6058 |
| September 30, 2021 | 0.0543 |
| June 30, 2021 | -0.3488 |
| March 31, 2021 | -0.1766 |
| December 31, 2020 | -0.2821 |
| September 30, 2020 | -0.3748 |
| June 30, 2020 | -0.3085 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3328 |
| December 31, 2019 | -0.3236 |
| September 30, 2019 | -0.3716 |
| June 30, 2019 | -0.2599 |
| March 31, 2019 | -0.3023 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.4067 |
| June 30, 2018 | -0.3645 |
| March 31, 2018 | -0.3934 |
| December 31, 2017 | -0.87 |
| September 30, 2017 | -0.75 |
| June 30, 2017 | -0.986 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
| Purple Biotech Ltd. | 0.4069 |
| PolyPid Ltd. | -0.3467 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.681M |
| Revenue (Quarterly) | 0.591M |
| Total Expenses (Quarterly) | 4.272M |
| Enterprise Value | 220.39M |
| Profit Margin (Quarterly) | -622.8% |
| Earnings Yield | -6.91% |
| Normalized Earnings Yield | -6.907 |